Skip to content
Recall Observatory FDA recall evidence

Drug product

Timolol-Brimonidine-Dorzolamide-Latanoprost (0.5/0.15/2/0.005)% Ophthalmic Drops, Sterile 5ml Bottle, Compounded for a licensed professional or patient use, imprimisRx, Irvine, CA

D-1133-2017

June 23, 2017

Class II

Product summary

Firm
ImprimisRx CA, Inc., dba ImprimisRx
Event
Event 77647
Status
Terminated
Classification
Class II
Quantity
2 bottles
Official record key
drug-enforcement:D-1133-2017

Official wording

Reason: Incorrect/Undeclared Excipient; non-pharmaceutical grade PEG 40 Castor Oil was used due to a mislabeling by the supplier

Code information: 05092017@2B, 11/5/2017

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    mislabeling